Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchitol in Bronchiectasis
NCT00277537Phase 3Completed
- Sponsor
- Syntara Limited
- Start
- Mar 2006
- Primary completion
- Jul 2008
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in bronchiectasis comparing Bronchitol Arm with Placebo Arm (2 arms). Primary endpoints: 24 hour sputum clearance at 12 weeks and St. George's Respiratory Questionnaire at 12 weeks. Started Mar 2006; status: completed.
02
Drugs
Bronchitol
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT00277537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00277537.